(+)-Blebbistatin

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Cell permeable: no

Reversible: no

Product does not compete with ATP.

Primary TargetInactive enantiomer of (±)-Blebbistatin

General description

The inactive enantiomer of (±)-Blebbistatin (Cat. No. 203390). Useful as a negative control for the active enantiomer (Cat. No. 203391).

The inactive enantiomer of (±)-Blebbistatin (Cat. No. 203390). Also useful as a negative control for the more active enantiomer (-)-Blebbistatin (Cat. No. 203391).

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Shu, S., et al. 2005. Proc. Natl. Acad. Sci. USA102, 1472.Jacobelli, J., et al. 2004. Nat. Immunol.5, 531.Kovacs, M., et al. 2004. J. Biol. Chem.279, 35557.Straight, A.F., et al. 2003. Science299, 1743.

Packaging

1 mg in Plastic ampoule

Packaged under inert gas

Reconstitution

Following reconstitution in methanol, aliquot and freeze (-20°C). Stock solutions in 90% DMSO or methanol are stable for up to 1 month at -20°C. Stock solutions in 100% DMSO are unstable; reconstitute just prior to use.

Warning

Toxicity: Harmful & Carcinogenic / Teratogenic (E)